These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24642873)

  • 21. Cytoreductive treatment patterns among US veterans with polycythemia vera.
    Parasuraman S; Yu J; Paranagama D; Shrestha S; Wang L; Baser O; Scherber R
    BMC Cancer; 2018 May; 18(1):528. PubMed ID: 29728092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular events and intensity of treatment in polycythemia vera.
    Marchioli R; Finazzi G; Specchia G; Cacciola R; Cavazzina R; Cilloni D; De Stefano V; Elli E; Iurlo A; Latagliata R; Lunghi F; Lunghi M; Marfisi RM; Musto P; Masciulli A; Musolino C; Cascavilla N; Quarta G; Randi ML; Rapezzi D; Ruggeri M; Rumi E; Scortechini AR; Santini S; Scarano M; Siragusa S; Spadea A; Tieghi A; Angelucci E; Visani G; Vannucchi AM; Barbui T;
    N Engl J Med; 2013 Jan; 368(1):22-33. PubMed ID: 23216616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulant-resistant thrombophilia in a patient with polycythemia vera: a case report.
    Das S; Karachiwala H; Cherian SV; Garcha AS; Jasti S; Gajra A
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):746-8. PubMed ID: 21885951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.
    Michiels JJ; Barbui T; Finazzi G; Fuchtman SM; Kutti J; Rain JD; Silver RT; Tefferi A; Thiele J
    Leuk Lymphoma; 2000 Jan; 36(3-4):239-53. PubMed ID: 10674896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors and prevention of vascular complications in polycythemia vera.
    Barbui T; Finazzi G
    Semin Thromb Hemost; 1997; 23(5):455-61. PubMed ID: 9387204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cytoreductive Therapy in Polycythemia Vera clinical trials.
    Barbui T; Carobbio A; Ghirardi A; Masciulli A; Rambaldi A; Vannucchi AM
    Haematologica; 2017 Jun; 102(6):e219-e221. PubMed ID: 28255021
    [No Abstract]   [Full Text] [Related]  

  • 27. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A
    Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial.
    Barbui T; Vannucchi AM; De Stefano V; Masciulli A; Carobbio A; Ferrari A; Ghirardi A; Rossi E; Ciceri F; Bonifacio M; Iurlo A; Palandri F; Benevolo G; Pane F; Ricco A; Carli G; Caramella M; Rapezzi D; Musolino C; Siragusa S; Rumi E; Patriarca A; Cascavilla N; Mora B; Cacciola E; Mannarelli C; Loscocco GG; Guglielmelli P; Betti S; Lunghi F; Scaffidi L; Bucelli C; Vianelli N; Bellini M; Finazzi MC; Tognoni G; Rambaldi A
    Lancet Haematol; 2021 Mar; 8(3):e175-e184. PubMed ID: 33476571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycythemia vera in a cat and management with hydroxyurea.
    Evans LM; Caylor KB
    J Am Anim Hosp Assoc; 1995; 31(5):434-8. PubMed ID: 8542363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-world treatments and thrombotic events in polycythemia vera patients in the USA.
    Verstovsek S; Pemmaraju N; Reaven NL; Funk SE; Woody T; Valone F; Gupta S
    Ann Hematol; 2023 Mar; 102(3):571-581. PubMed ID: 36637474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How I treat patients with polycythemia vera.
    Finazzi G; Barbui T
    Blood; 2007 Jun; 109(12):5104-11. PubMed ID: 17264301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Front-line therapy in polycythemia vera and essential thrombocythemia.
    Barbui T; Finazzi MC; Finazzi G
    Blood Rev; 2012 Sep; 26(5):205-11. PubMed ID: 22784966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycythemia vera.
    Landolfi R; Nicolazzi MA; Porfidia A; Di Gennaro L
    Intern Emerg Med; 2010 Oct; 5(5):375-84. PubMed ID: 20237866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2015 Feb; 90(2):162-73. PubMed ID: 25611051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in Polycythemia Vera.
    Barbui T; De Stefano V; Ghirardi A; Masciulli A; Finazzi G; Vannucchi AM
    Blood Cancer J; 2018 Nov; 8(12):124. PubMed ID: 30478311
    [No Abstract]   [Full Text] [Related]  

  • 36. Bumpy road to the diagnosis of polycythaemia vera.
    Gameiro RS; Rodrigues A; Gonçalves FM; Graça JP
    BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28280082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythromelalgia and vascular complications in polycythemia vera.
    Michiels JJ
    Semin Thromb Hemost; 1997; 23(5):441-54. PubMed ID: 9387203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.
    Bellucci S; Michiels JJ
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):381-98. PubMed ID: 16810614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematocrit levels and thrombotic events in patients with polycythemia vera: an analysis of Veterans Health Administration data.
    Parasuraman S; Yu J; Paranagama D; Shrestha S; Wang L; Baser O; Scherber R
    Ann Hematol; 2019 Nov; 98(11):2533-2539. PubMed ID: 31552445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [When should a myeloproliferative syndrome be suggested in vascular medicine?].
    Lazareth I; Delarue R; Priollet P
    J Mal Vasc; 2005 Feb; 30(1):46-52. PubMed ID: 15924069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.